Literature DB >> 19141452

T-cell intrinsic expression of MyD88 is required for sustained expansion of the virus-specific CD8+ T-cell population in LCMV-infected mice.

Christina Bartholdy1, Jeanette E Christensen1, Mirjana Grujic1, Jan P Christensen1, Allan R Thomsen1.   

Abstract

Acute infection with lymphocytic choriomeningitis virus (LCMV) normally results in robust clonal expansion of virus-specific CD8(+) T cells, which in turn control the primary infection. However, similar infection of myeloid differentiation factor 88 (MyD88)-deficient mice leads to a markedly impaired T-cell response and chronic infection. It has been found previously that impairment of the innate immune response is not sufficient to explain this profound change in outcome. Using adoptive transfer of CD8(+) T cells, this study demonstrated unequivocally that T-cell expression of MyD88 is critical for a normal T-cell response to LCMV. In addition, it was found that expression of MyD88 is superfluous during early activation and proliferation of the antigen-activated CD8(+) T cells, but plays a critical role in the sustained expansion of the antigen-specific CD8(+) T-cell population during the primary T-cell response. Interestingly, a critical role for MyD88 was evident only under conditions of systemic infection with virus capable of causing prolonged infection, suggesting that MyD88 expression may function as an internal regulator of the threshold for antigen-driven, exhaustive differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141452     DOI: 10.1099/vir.0.004960-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  21 in total

1.  Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine.

Authors:  Basav N Hangalapura; Dinja Oosterhoff; Tarun Gupta; Jan de Groot; Pepijn G J T B Wijnands; Victor W van Beusechem; Joke den Haan; Thomas Tüting; Alfons J M van den Eertwegh; David T Curiel; Rik J Scheper; Tanja D de Gruijl
Journal:  Vaccine       Date:  2011-01-25       Impact factor: 3.641

2.  Interleukin-1R signaling is essential for induction of proapoptotic CD8 T cells, viral clearance, and pathology during lymphocytic choriomeningitis virus infection in mice.

Authors:  Lars T Joeckel; Reinhard Wallich; Sunil S Metkar; Christopher J Froelich; Markus M Simon; Christoph Borner
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

3.  MyD88 in antigen-presenting cells is not required for CD4+ T-cell responses during peptide nanofiber vaccination.

Authors:  Youhui Si; Yi Wen; Jianjun Chen; Rebecca R Pompano; Huifang Han; Joel Collier; Anita S Chong
Journal:  Medchemcomm       Date:  2017-11-29       Impact factor: 3.597

4.  Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.

Authors:  Zhaoyang Li; Kenisha Younger; Ronald Gartenhaus; Ann Mary Joseph; Fang Hu; Maria R Baer; Patrick Brown; Eduardo Davila
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 5.  Effects of Toll-like receptor signals in T-cell neoplasms.

Authors:  Cori Morrison; Maria R Baer; Dan P Zandberg; Amy Kimball; Eduardo Davila
Journal:  Future Oncol       Date:  2011-02       Impact factor: 3.404

6.  Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88.

Authors:  Adeeb H Rahman; Ruan Zhang; Christopher D Blosser; Baidong Hou; Anthony L Defranco; Jonathan S Maltzman; E John Wherry; Laurence A Turka
Journal:  Blood       Date:  2011-01-13       Impact factor: 22.113

7.  Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice.

Authors:  Philippe Krebs; Karine Crozat; Daniel Popkin; Michael B Oldstone; Bruce Beutler
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

8.  Amplifying TLR-MyD88 signals within tumor-specific T cells enhances antitumor activity to suboptimal levels of weakly immunogenic tumor antigens.

Authors:  Degui Geng; Liqin Zheng; Ratika Srivastava; Cruz Velasco-Gonzalez; Adam Riker; Svetomir N Markovic; Eduardo Davila
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

9.  Conserved Gammaherpesvirus Protein Kinase Selectively Promotes Irrelevant B Cell Responses.

Authors:  Eric J Darrah; Christopher N Jondle; Kaitlin E Johnson; Gang Xin; Philip T Lange; Weiguo Cui; Horatiu Olteanu; Vera L Tarakanova
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 10.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.